$7.27
Sera Prognostics is a medical devices business based in the US. Sera Prognostics shares (SERA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.67 – an increase of 9.57% over the previous week. Sera Prognostics employs 55 staff and has a trailing 12-month revenue of around $107,000.
Our top picks for where to buy Sera Prognostics stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Sera Prognostics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SERA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Sera Prognostics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Sera Prognostics stock price (NASDAQ: SERA)
Use our graph to track the performance of SERA stocks over time.Sera Prognostics shares at a glance
Latest market close | $7.67 |
---|---|
52-week range | $1.56 - $12.36 |
50-day moving average | $7.29 |
200-day moving average | $7.97 |
Wall St. target price | $2.75 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.98 |
Is it a good time to buy Sera Prognostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sera Prognostics price performance over time
Historical closes compared with the close of $7.67 from 2024-10-18
1 week (2024-10-11) | 9.57% |
---|---|
1 month (2024-09-20) | 3.65% |
3 months (2024-07-19) | -1.67% |
6 months (2024-04-19) | -21.33% |
1 year (2023-10-20) | 338.29% |
---|---|
2 years (2022-10-20) | 428.97% |
3 years (2021-10-20) | 10.75 |
5 years (2019-10-16) | N/A |
Sera Prognostics financials
Revenue TTM | $107,000 |
---|---|
Gross profit TTM | $75,000 |
Return on assets TTM | -24.36% |
Return on equity TTM | -44.77% |
Profit margin | 0% |
Book value | $1.79 |
Market Capitalization | $238.9 million |
TTM: trailing 12 months
Sera Prognostics share price volatility
Over the last 12 months, Sera Prognostics's shares have ranged in value from as little as $1.56 up to $12.355. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sera Prognostics's is 1.034. This would suggest that Sera Prognostics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Sera Prognostics's beta into context you can compare it against those of similar companies.
- Quest Diagnostics Incorporated (DGX.US): 0.888
- Johnson-and-Johnson (JNJ.US): 0.518
- Bio-Rad Laboratories (BIO.US): 0.947
Sera Prognostics overview
Sera Prognostics, Inc. , a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. .
Frequently asked questions
What percentage of Sera Prognostics is owned by insiders or institutions?Currently 12.741% of Sera Prognostics shares are held by insiders and 71.463% by institutions. How many people work for Sera Prognostics?
Latest data suggests 55 work at Sera Prognostics. When does the fiscal year end for Sera Prognostics?
Sera Prognostics's fiscal year ends in December. Where is Sera Prognostics based?
Sera Prognostics's address is: 2749 East Parleys Way, Salt Lake City, UT, United States, 84109 What is Sera Prognostics's ISIN number?
Sera Prognostics's international securities identification number is: US81749D1072
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Seelos Therapeutics stock (SEEL)
Steps to owning and managing SEEL, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Moderna stock (MRNA)
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question